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The biocompatibility of peptide-based hydrogels make them ideal for biomedical applications such 
as drug delivery, biosensing, tissue engineering and wound healing [1,2]. However, the enzymatic 
hydrolysis of these materials can be regarded as a serious disadvantage. One way to increase the 
biostability of this type of hydrogels consists in using non-proteinogenic amino acids. In this work, 
several new hydrogelators were developed, containing a Naproxen or a Naphthalene group, and 
their critical aggregation concentrations were determined by fluorescence. The influence of pH on 
the aggregation of these molecules was also investigated. TEM images revealed that these 
hydrogels contain entangled nanofibers, with width ranging from 9 nm to 18 nm (Figure 1). 
The ability of these hydrogels to act as nanocarriers for antitumor drugs was investigated. FRET 
(Förster Resonance Energy Transfer) assays were performed between the several hydrogels (acting 
as energy donors) and a new antitumor fluorescent thienopyridine derivative [3] (acting as energy 
acceptor). Donor-acceptor distances between 2.5 nm and 3.5 nm were determined. The results 
obtained confirm that the peptide-based hydrogels can be used as drug nanocarriers.  
As the antitumor compound tested is especially active against human melanoma cell lines 
(GI50=3.5 µM) [3], these results are promising to the development of hydrogel formulations for 
topical application. 
 
 
 
 
 
 
Figure 1. TEM images of two hydrogels: Npx-Phe-ΔPhe-OH (A) and Npx-Phe-ΔAbu-OH (B). 
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